---
title: "Shenqi (900904.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/900904.SH.md"
symbol: "900904.SH"
name: "Shenqi"
industry: "Pharmaceuticals"
---

# Shenqi (900904.SH)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |

## Company Profile

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumati...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:10.000Z

**Overall: C (0.45)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 178 / 222 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -14.92% |  |
| Net Profit YoY | 22.55% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.81 |  |
| Dividend Ratio | 4.08% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.89B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.80B |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 2.66% | C |
| Profit Margin | 3.31% | C |
| Gross Margin | 49.36% | B |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -14.92% | E |
| Net Profit YoY | 22.55% | B |
| Total Assets YoY | -5.36% | D |
| Net Assets YoY | -2.06% | D |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 3021.37% | A |
| OCF YoY | -14.92% | E |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.60 | B |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 21.93% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Shenqi",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "2.66%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "3.31%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "49.36%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-14.92%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "22.55%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.36%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-2.06%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "3021.37%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "-14.92%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.60",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "21.93%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Allist (SH.688578) | A | A | B | A | B | A |
| 02 | Xingqi Pharmaceutical (SZ.300573) | A | A | A | B | B | A |
| 03 | Hengrui Pharma (SH.600276) | A | B | C | A | B | B |
| 04 | Yunnan Baiyao (SZ.000538) | B | C | B | B | C | B |
| 05 | Salubris (SZ.002294) | B | B | C | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 30.25 | 72/222 | 33.83 | 31.22 | 30.31 |
| PB | 0.81 | 3/222 | 0.87 | 0.84 | 0.81 |
| PS (TTM) | 1.00 | 7/222 | 1.05 | 1.01 | 0.97 |
| Dividend Yield | 4.08% | 12/222 | 4.10% | 4.00% | 2.80% |

## References

- [Company Overview](https://longbridge.com/en/quote/900904.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/900904.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/900904.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
